Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Carbidopa »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Carbenoxolone < Carbidopa < Carbimazole  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 128.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000045 (1999) R B Innis [États-Unis] ; K L Marek ; K. Sheff ; S. Zoghbi ; J. Castronuovo ; A. Feigin ; J P SeibylEffect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.
000063 (1999) L E Davis [États-Unis] ; J C AdairParkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.
000153 (1999) J E Ahlskog [États-Unis] ; R J Uitti ; M K O'Connor ; D M Maraganore ; J Y Matsumoto ; K F Stark ; M F Turk ; O L BurnettThe effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
000159 (1999) J. Kimber [Royaume-Uni] ; L. Watson ; C J MathiasNeuroendocrine responses to levodopa in multiple system atrophy (MSA).
000168 (1999) C. Dentresangle [France] ; L. Veyre ; D. Le Bars ; C. Pierre ; F. Lavenne ; P. Pollak ; J. Guerin ; J C Froment ; E. BrousolleStriatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.
000200 (2000) L M Shulman [États-Unis] ; A. Minagar ; W J WeinerThe effect of pregnancy in Parkinson's disease.
000272 (2000) R A Hauser [États-Unis] ; W C Koller ; J P Hubble ; T. Malapira ; K. Busenbark ; C W OlanowTime course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
000274 (2000) M D Welsh [États-Unis] ; E. Dorflinger ; D. Chernik ; C. WatersIllness impact and adjustment to Parkinson's disease: before and after treatment with tolcapone.
000280 (2000) P E Greene [États-Unis] ; S B Bressman ; B. Ford ; K. HylandParkinsonism, dystonia, and hemiatrophy.
000390 (2000) K J Black [États-Unis] ; J W MinkResponse to levodopa challenge in Tourette syndrome.
000676 (2002) Elena Meseguer [Espagne] ; Rocio Taboada ; Vicenta Sánchez ; María Angeles Mena ; Victor Campos ; Justo García De YébenesLife-threatening parkinsonism induced by kava-kava.
000721 (2002) Ruth Djaldetti [Israël] ; Rivkah Inzelberg ; Nir Giladi ; Amos D. Korczyn ; Yehudit Peretz-Aharon ; Martin J. Rabey ; Yuval Herishano ; Silvia Honigman ; Sami Badarny ; Eldad MelamedOral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease.
000745 (2002) Ashfaq A. Sharif [États-Unis]Entacapone in restless legs syndrome.
000834 (2002) Miriam Vélez [Pérou] ; Carlos Cosentino ; Luis TorresLevodopa-responsive rubral (Holmes') tremor.
000895 (2002) Robert A. Hauser [États-Unis] ; Nicholas H G. HolfordQuantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
000926 (2002) Marie-Paule Muriel [France] ; Gaël Orieux ; Etienne C. HirschLevodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats.
000957 (2002) Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra ; Robert A. HauserClozapine withdrawal symptoms in a Parkinson's disease patient.
000995 (2003) Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] ; Donna L. Macintyre [Canada] ; A. Jon StoesslLeg muscle strength is reduced in PD and relates to the ability to rise from a chair
000A52 (2003) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Matthew J. Hansard ; Eleni Maratos ; Peter JennerEffect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure.
000C82 (2004) Matthew J. Hansard [Royaume-Uni] ; Lance A. Smith ; Michael J. Jackson ; Sharon C. Cheetham ; Peter JennerThe monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates.
000C83 (2004) Connie Marras [Canada] ; Anthony Lang ; Murray Krahn ; George Tomlinson ; Gary NaglieQuality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Carbidopa" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Carbidopa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Carbidopa
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024